Fig. 1From: The early clinical and laboratory predictors of GBS outcome: hospital-based study, Assiut University, Upper EgyptSpearman correlations of MRC sum score at the 10th day after treatment and Erasmus Guillain–Barré Respiratory Insufficiency Score (EGRIS) at onset with 3-month outcome measured with the Hughes Disability Scale (HDS) and Overall Neuropathy Limitation Scale (ONLS). Outcomes in both scores were significantly correlated with MRC sum score at the 10th day of treatment and EGRIS at onsetBack to article page